Literature DB >> 25906109

Amyloid burden in the hippocampus and default mode network: relationships with gray matter volume and cognitive performance in mild stage Alzheimer disease.

Ya-Ting Chang1, Chi-Wei Huang, Yen-Hsiang Chang, Nai-Ching Chen, Kun-Ju Lin, Tzu-Chen Yan, Wen-Neng Chang, Sz-Fan Chen, Chun-Chung Lui, Pin-Hsuan Lin, Chiung-Chih Chang.   

Abstract

Amyloid load, as measured by florbetapir positron emission tomography (PET) standardized uptake value ratio (SUVr), has high specificity in the diagnosis of Alzheimer disease (AD). As the posterior cingulate cortex (PCC) represents densely amyloid-affected regions early in AD, we hypothesized that amyloid load within the key hubs of the default mode networks (DMN) may result in local or distant interconnected gray matter (GM) volume atrophy, thereby affecting cognitive performance. Thirty AD patients with a clinical dementia rating sum of box score ≤2 were enrolled and underwent cognitive evaluation, 3-dimensional T1-weighted imaging and florbetapir PET. Volumes of interest (VOIs) included the hippocampus, lateral temporal region, and key hubs of the DMN [anterior cingulate cortex (ACC), PCC, posterior parietal, and precuneus]. The SUVr was calculated by florbetapir standard uptake value (SUV) within the T1-weighted image segmented GM VOIs divided by the cerebellar GM SUV. Our results suggested inverse correlations between ACC (ρ = -0.444, P = 0.016) and PCC SUVr (ρ = -0.443, P = 0.016) with PCC GM volume. In stepwise regression, the orientation scores were associated with PCC SUVr (β = 2.584, P = 0.02) and posterior parietal volume (β = -0.446, P = 0.04), whereas the word recall score was related to hippocampal volume (β = -0.391, P = 0.04). After removing the patients with a hippocampal VOI below the lowest tertile and adjusting for age, an inverse correlation was found between hippocampal volume and SUVr in the ACC (partial σ = -0.639, P = 0.002), precuneus (partial σ = -0.692, P = 0.002), and lateral temporal SUVr (partial σ = -0.604, P = 0.005). Our results suggest that amyloid burden within the key DMN regions may contribute to local and distant GM atrophy, and that this may explain the cognitive scores.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25906109      PMCID: PMC4602683          DOI: 10.1097/MD.0000000000000763

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


INTRODUCTION

The International Working Group-2 criteria for Alzheimer disease (AD)[1] recently redefined the clinical use of amyloid and glucose positron emission tomography (PET). Amyloid PET is considered to be a diagnostic marker that reflects in vivo pathology, whereas glucose PET is considered to represent a marker of downstream disease progression that reflects clinical severity. It has been hypothesized that with regards to amyloid-β in AD, self-aggregation of amyloid fibrils and accumulation of amyloid plaques would result in downstream network degeneration.[2] The characteristic glucose PET patterns[1] in AD are hypometabolism in the anterior cingulate cortex (ACC), posterior cingulate cortex (PCC), precuneus, and temporo-parietal regions, collectively termed the default mode network (DMN).[3] As cortical hubs within the DMN network represent early pathological targets in AD and are also highly functionally anchored, changes in cognitive scores may reflect local amyloid toxicity or related neuronal degeneration. Using the amyloid tracer 11C Pittsburgh compound B, increased uptake in the PCC region can be detected early in AD, whereas uptake in the hippocampus and DMN key hubs has been associated with regional gray matter (GM) atrophy.[4] In cognitively normal elderly subjects, Oh et al[5] also observed that greater amyloid deposition in the DMN regions was associated with a greater loss in GM volume. Another study showed that regional florbetapir (AV-45) uptake using standardized uptake value ratio (SUVr) quantification achieved 96% sensitivity and 100% specificity in reflecting moderate-to-frequent neuritic plaques.[6] Until recently, florbetapir PET has been considered to be a valid clinical tool in the diagnosis of AD.[7] Rosenberg et al[8] reported significant inverse correlations between verbal fluency score with precuneus florbetapir SUVr. However, it is not known whether cognitive relationships exist in other DMN hubs and how they are linked with changes in regional GM volume. It is generally accepted that regional atrophy has a significant impact on the quantitative accuracy of PET imaging.[9] Current morphometric analysis techniques in magnetic resonance imaging (MRI) allow for accurate brain tissue segmentation into GM, white matter or nonbrain regions.[10] With an MRI-based coregistration algorithm, it is possible to quantify regional GM amyloid burden. The issue of appropriate head size adjustment has also been reported in the context of cortical structure changes in the elderly.[11] Normalization of regional brain volumes by total intracerebral volume (ICV) [ie, the ratio between the volume of interest (VOI) and ICV] is often performed in disorders involving neurodegeneration,[12] as well as adjustments for age or educational level when investigating regional volume data with cognitive scores. In addition, it is also known that changes in certain brain cortical structures such as hippocampal formation and middle and inferior temporal cortical structures are disproportional to other GM structures in AD.[13] Use of ICV-normalized method might mask the changes related directly to pathology or in tissues with small volumes. In the literature, both raw regional volume[14,15] and volume-to-ICV fraction[16] have been used to investigate volumetric–cognitive relationships in AD. As the PCC area represents a densely amyloid-affected region early in AD,[17,18] we hypothesized that amyloid load within the key hubs of the DMN could result in local or distant connected GM volume atrophy, thereby affecting cognitive performance. In addition, since amyloid load often reaches a plateau at the dementia stage,[19] the proof of concept of amyloid toxicity to morphologic or cognitive changes would theoretically be more feasible by selecting AD patients at a milder clinical stage. Based on image coregistration with GM-segmented high-resolution T1-weighted images, the florbetapir SUVr in 6 VOIs was calculated using the cerebellar GM as a reference region. For clinical correlation, we used the Alzheimer Disease Assessment Scale-cognitive subscale (ADAS-cog),[20] a tool commonly used in patients with AD, to represent the cognitive performance. To examine whether volumetric measurements correlated with cognitive scores, both raw volume data expressed in cubic millimeters and ICV-normalized volume data were recorded.

METHODS

Inclusion and Exclusion Criteria

This was a single-center, prospective, and observational study. The patients were recruited from the Department of Neurology of Chang Gung Memorial Hospital from 2011 to 2014. All of the patients underwent comprehensive neurological and neuropsychological assessments with consensus rendered at a multidisciplinary conference.[21,22] AD was diagnosed according to the International Working Group criteria for AD.[23] Only patients with a clinical dementia rating (CDR)[24] sum of box score ≤2.0 and positive reading results on florbetapir PET[25] were selected. The rationale for choosing this CDR criterion was to avoid floor effects of cognitive performance and also to reach an earlier clinical stage prior to the plateau of amyloid deposition. All of the patients received acetylcholine esterase inhibitors from the time of diagnosis. The exclusion criteria were a history of clinical stroke, a modified Hachinski ischemic score > 4,[26] and depression. The hospital's Human Ethics Committee approved the study protocol, and all of the participants and their authorized caregivers provided written informed consent. AV-45 PET scan, cognitive testing, and MRI were all performed within a 4-week period.

MRI Acquisition and Volumetric Analysis

MRI was performed using a GE 3T Signa Excite scanner. Structural images were acquired for anatomic reference and to verify the clinical diagnosis using the following protocols T2-weighted, turbo spin-echo sequence with repetition time/echo time/number of averages of 4200/101.2 ms/2, 240 × 240 mm field of view, 320 × 224 matrix, and 5-mm axial slice thickness; and T1-weighted, inversion-recovery-prepared, 3-dimensional, spoiled, gradient-recalled acquisition in a steady-state sequence with repetition time/inversion time of 8600/450 ms, 240 × 240 mm field of view, and 1-mm slice thickness. The preprocessing of T1 MRI involves removal of nonrelevant tissue, intensity normalization, and automatic Talairach transformation and segmentation. We used the Automated Anatomic Labeling atlas[27] for regional labeling and volumetric calculation. In addition to the DMN cortical regions (posterior parietal, precuneus, ACC, and PCC), we also included the lateral temporal region (ie, superior, middle, and inferior lateral temporal regions) and hippocampal formation as VOIs (Figure 1).
FIGURE 1

Map of the volumes of interest on brain MRI. (A) Coronal view. (B) Sagittal view. (C) Axial view. (D) Fusion of PET and MRI. MRI = magnetic resonance imaging, PET = positron emission tomography.

Map of the volumes of interest on brain MRI. (A) Coronal view. (B) Sagittal view. (C) Axial view. (D) Fusion of PET and MRI. MRI = magnetic resonance imaging, PET = positron emission tomography. High intrasubject correlations between the right and left hemispheres were found among all 6 VOIs [from highest σ = 0.951 (P < 0.001) for the hippocampus to lowest σ = 0.824 (P < 0.001) for the ACC]. The average of left and right corresponding VOIs was used for statistical analysis.

AV-45 PET Acquisition and Analysis

AV-45 was synthesized at the cyclotron facility of Chang Gung Memorial Hospital. The PET acquisition protocol, optimal scanning time, and image reconstruction followed a previous report.[25] In brief, helical computed tomography images were obtained for attenuation correction at 40 minutes. Each PET acquisition consisted of 3 5-minute dynamic frames obtained 50 minutes postinjection in 3-dimensional mode using a Biography molecular computed tomography PET/computed tomography system (Siemens Medical Solutions, Malvern, PA). Summed images were subsequently created for further analysis. The PET images were first coregistered to the 3-dimensional T1 images by a nonlinear transformation using Statistical Parametric Mapping 8 software (Wellcome Trust Centre of Cognitive Neurology, University College London, London, UK). The 6 VOIs defined from the MRI were transferred to the coregistered PET images. A representative example of the fusion imaging between the MRI and PET images is shown in Figure 1D. The cerebellar GM represented the reference region (Figure 1B, green region). The SUV is related to injection dose and normalized to body weight. The SUVr was calculated by determining the ratios of SUV between the target VOI and the reference region. Intrasubject Spearman correlations between the SUVr of the right and left hemispheres were high. The correlation coefficient for the lateral temporal region was σ = 0.738 (P < 0.001), precuneus σ = 0.935 (P < 0.001), ACC σ = 0.797 (P < 0.001), PCC σ = 0.864 (P < 0.001), posterior parietal σ = 0.940 (P < 0.001), and hippocampus σ = 0.818 (P < 0.001).

Neuropsychological Assessment

A trained neuropsychologist administered the tests. Cognitive function was assessed using the minimental state examination[28] and the 11-item Chinese version of the ADAS-cog.[20]

Statistical Analysis

All values were expressed as mean ± standard deviation (SD). To assess the relationships between continuous variables including SUVr, cognitive test score, volumetric data, age, and education, Pearson correlation coefficients or Spearman rank correlation coefficients were calculated with a corresponding two-sided significance test at the 0.05 significance level. To assess the appropriateness of using parametric statistics for these analyses, we used the Kolmogorov–Smirnov test to examine the normality, and P values >0.05 indicated no significant deviations from normality. Both raw GM volume and ICV-normalized volume data (calculated by expressing the VOI as a proportion of the ICV) were recorded for further cognitive correlations. For volumetric measurements that correlated with regional SUVr or cognitive performance, age was entered as a covariate of no interest. Stepwise regression was carried out to determine the best predictors of cognitive score. Each model used SUVr or volumetric data, age, and education level (in years) as independent variables. All statistical analyses were conducted using the Statistical Package for Social Sciences software package (version 18 for Windows, SPSS Inc, Chicago, IL).

RESULTS

Clinical and Imaging Data

After the initial screening, 30 patients (15 males) with a mean age of 76.6 ± 8.0 years (range, 62–89 years) and an educational level of 8.6 ± 5.4 years (range, 0–18 years) completed the study. The total GM AV-45 SUVr was 1.29 ± 0.2 (range, 0.81–1.75), and in descending order was PCC 1.54 ± 0.4 (range, 0.99–2.71), precuneus 1.48 ± 0.3 (range, 0.84–2.21), ACC 1.47 ± 0.4 (range, 0.8–2.25), lateral temporal 1.34 ± 0.3 (range, 0.8–1.98), posterior parietal 1.27 ± 0.3 (range, 0.61–1.89), and hippocampus 0.002 ± 0.0003 (range, 0.001–0.0022). The ICV-normalized VOIs were ACC 0.326% ± 0.035%, PCC 0.163% ± 0.018%, posterior parietal 1.098% ± 0.122%, lateral temporal 2.639% ± 0.355%, precuneus 0.772% ± 0.121%, and hippocampus 0.182% ± 0.042%. There was a significant correlation between age and ADAS-cog score (σ = 0.367, P = 0.04). The total GM volume was correlated with minimental state examination score, ADAS-cog total, and subdomain scores including orientation, instruction remembering, and comprehension (Table 1). There were no significant correlations between total SUVr and the cognitive tests.
TABLE 1

Clinical Data of the Alzheimer Disease Patients (n = 30)

Clinical Data of the Alzheimer Disease Patients (n = 30)

Relationship Between Volumetric Measurements and SUVr Within the VOIs

There were significant inverse correlations between ACC SUVr and raw volumes of the ACC (ρ = −0.371, P = 0.04) and PCC (ρ = −0.479, P = 0.01), and between PCC SUVr with the volume of the ACC (ρ = −0.434, P = 0.02), PCC (ρ = −0.494, P = 0.01), and precuneus (ρ = −0.367, P < 0.05) (Table 2). After ICV normalization, significant inverse correlations were found between ACC SUVr (ρ = −0.444, P = 0.016) or PCC SUVr (ρ = −0.443, P = 0.016) and PCC volume (Table 2).
TABLE 2

Relationships Between Regional Cortical Volume and SUVr

Relationships Between Regional Cortical Volume and SUVr Although there were no correlations between the ACC, precuneus or lateral temporal AV-45 SUVr, and hippocampal volume, the scatter plot showed a concave pattern (Figure 2A–C). We further removed the patients with a hippocampal VOI below the lowest tertile. After adjusting for age, there were significant linear relationships between the ICV-normalized hippocampal volume and SUVr in the ACC (partial σ = −0.639, R2 = 0.718, P = 0.002), precuneus (partial σ = −0.692, R2 = 0.3076, P = 0.001), and lateral temporal (partial σ = −0.604, R2 = 0.2837, P = 0.005) (Figure 2D–F).
FIGURE 2

Scatter plot of the age-adjusted ICV normalized hippocampus volume with AV-45 SUVr) values in the ACC (A), precuneus (B), and lateral temporal region (C). Corresponding fitting curves in the 3 areas (D–F) in patients with a relatively preserved hippocampal volume. ACC = anterior cingulate cortex, ICV =  intracerebral volume, SUVr = standard uptake value ratio.

Scatter plot of the age-adjusted ICV normalized hippocampus volume with AV-45 SUVr) values in the ACC (A), precuneus (B), and lateral temporal region (C). Corresponding fitting curves in the 3 areas (D–F) in patients with a relatively preserved hippocampal volume. ACC = anterior cingulate cortex, ICV =  intracerebral volume, SUVr = standard uptake value ratio.

Independent Role of PCC SUVr With Orientation Scores

The only significant relationship between SUVr and the cognitive variables was found between the PCC SUVr and the orientation score (r = 0.441, P = 0.02) (Table 3). Therefore, we further calculated the composite orientation score to recheck the results. This was composed of the orientation box score of the CDR and the ADAS-cog orientation test score with each measure carrying the same weight. The PCC SUVr consistently showed an association with the composite orientation score (P < 0.05), and this association was still significant after stepwise regression analysis (Table 3). There was no significant association between PCC volume and orientation score or composite orientation score.
TABLE 3

Correlation of Regional SUVr With Cognitive Test Performance

Correlation of Regional SUVr With Cognitive Test Performance

Independent Role of Volumetric Measurements With Orientation Scores

For the volumetric measurements that explained the orientation score, significant relationships were seen in the posterior parietal (ρ = −0.499, P = 0.01), precuneus (ρ = −0.486, P = 0.01), and ACC (ρ = −0.498, P = 0.01), whereas significance with composite orientation score was also seen in the volume of posterior parietal (ρ = −0.527, P = 0.01), precuneus (ρ = −0.506, P = 0.01), and ACC (ρ = −0.490, P = 0.01). This observation remained significant in the stepwise regression model. A larger posterior parietal volume was associated with better performance in the ADAS-cog (β = −0.498, R2 = 0.226, t = −2.934, P = 0.01), orientation score (β = −0.478, R2 = 0.259, t = −2.714, P = 0.01), and composite orientation score (β = −0.506, R2 = 0.312, t = −2.983, P = 0.01), and a larger ACC was associated with a better performance in orientation score (β = −0.470, R2 = 0.251, t = −2.652, P = 0.01) and composite orientation score (β = −0.472, R2 = 0.279, t = −2.718, P = 0.01). After ICV normalization, significant relationships were seen between the orientation score and volume of posterior parietal (ρ = −0.425, P = 0.02) and precuneus (ρ = −0.463, P = 0.01), whereas significance with composite orientation score was also seen in the volume of posterior parietal (ρ = −0.478, P = 0.01) and precuneus (ρ = −0.504, P = 0.01). In the stepwise regression model, a larger posterior parietal volume was associated with better performance in orientation score (β = −0.446, R2 = 0.254, t = −2.240, P = 0.04) and composite orientation score (β = −0.494, R2 = 0.321, t = −2.599, P = 0.02).

Independent Role of Volumetric Measurements With Memory Score

The word recall subdomain score represented the memory domain in this study, and significance was found in the raw volume of hippocampus (β = −0.412, R2 = 0.186, t = −2.314, P = 0.029), PCC (β = −0.391, R2 = 0.171, t = −2.185, P = 0.038), and lateral temporal region (β = −0.378, R2 = 0.161, t = −2.101, P = 0.046). In the regression analysis, the independent relationships between the aforementioned VOIs with the word recall subdomain remained significant (β = −0.393 for hippocampus; β = −0.255 for PCC, and β = −0.235 for lateral temporal volume; P = 0.035). After ICV normalization, significant relationships were found between word recall score and hippocampal volume (ρ = −0.368, P = 0.049) and lateral temporal volume (ρ = −0.392, P = 0.04). In the regression analysis, only hippocampal ICV-normalized volume showed a significant relationship with the word recall subdomain score (β = −0.391, R2 = 0.265, t = −2.158, P = 0.04).

DISCUSSION

Major Findings

This study investigated the associations between amyloid load and related volumetric measurements and cognitive test scores in mild stage AD, and there were 3 major findings. First, the results may suggest different clinical roles when considering AV-45 SUVr and volumetric data. Although the ACC and PCC AV-45 SUVr were both related to volume reductions in PCC, our results showed the influence of amyloid load on local and distant interconnected DMN cortical hubs. Second, significant correlations were seen between the PCC SUVr and the orientation scores that were not mediated by the PCC volume. Therefore, orientation scores may be mediated directly by local amyloid load or alternatively via reductions in GM in the interconnected posterior parietal regions. Third, the isolated amyloid load within the DMN was insufficient to explain the salient memory deficits, whereas relationships were only seen in the ICV-normalized hippocampal volumetric correlations. Therefore, although a direct influence of amyloid burden on cognitive deficit is still possible, our results suggest that a more sophisticated trajectory of cognitive deficits in mild stage AD may be predominantly modulated via degeneration of the interconnected DMN network.

Independent Role of PCC AV45 Burden on Orientation Scores

It is well known that the amyloid pathological process precedes both neuronal degeneration and clinical symptoms in AD.[29] Although AV-45 PET imaging signals have been confirmed to reflect amyloid pathology,[6,30] it is difficult in terms of temporal relationship to predict the onset of an individual cognitive deficit. PCC remains an early target of amyloid deposition whether in patients with AD[17] or in cognitively normal subjects with a positive family history of AD.[18] As our results showed that a higher AV-45 PCC SUVr was related to lower orientation composite score, the direct relationship between amyloid burden and cognitive outcome pointed to the importance of PCC. Specifically, although the orientation score is not a key presenting feature in diagnosing AD, it still represents one of the cognitive domains involved in the relatively early stage of AD. The PCC, consisting of Brodmann areas 29, 30, 23, and 31 contains neurons that monitor eye movements and respond to sensory stimuli. The relationship between orientation scores and PCC SUVr in our study is consistent with a previous study in which a correlation between sensory events within the PCC was reported to explain the spatial orientation score.[31] Although using amyloid load to assess the degree of cognitive impairment seems to be flawed in AD, our results were significant for patients with mild stage AD and after quantifying amyloid load within the corresponding GM, normalized to ICV in volumetric calculations, and in the statistical analysis which minimized possible confounding factors including educational level and age. The monitoring of amyloid-β toxicity for the effect on individual cognition performance apparently requires an earlier scanning window, whereas local AV-45 SUVr still provides clinical value in predicting cognitive performance. Our findings of regional amyloid burden within PCC regions with cognitive deficits add to the growing literature that AV-45 PET can help to quantify the pathophysiology in certain cognitive domains.[8,32]

Amyloid Load With Related Interconnected Volume Atrophy Targeting the ACC–PCC axis

Our results showed inverse correlations between ACC or PCC SUVr with PCC volume. The regional-specific relationships between AV-45 uptake and volumetric data in the PCC region may suggest concomitant amyloid toxicity that is directly linked to neuronal injury. Alternatively, it is also possible that the atrophic findings observed in our results encompass other pathological processes that are mechanistically linked to amyloid cascade. Meanwhile, the link between ACC amyloid load and a reduction in PCC volume here also implies that amyloid burden may disrupt connectivity in the functionally interconnected ACC–PCC axis.[33] Further studies may be needed to verify our observations linking amyloid load with related network degeneration in AD, since high levels of ACC, PCC, or precuneus amyloid load have also been reported to be associated with very restricted regional atrophy.[34] Nonetheless, a degenerative theme has also been reported by 2 other studies on elderly subjects.[5,35]

Hippocampus Volume Predicted Memory Scores

Episodic memory impairment is a salient feature of AD. Our results showed an inverse correlation between word recall subdomain score and ICV-normalized hippocampal volume.[36,37] In contrast, none of the VOI SUVr showed clinical predictive value. In mild stage AD, the lack of relationships between amyloid-β burden and memory scores may indicate a protective cognitive reserve that may mask the pathological process of amyloid-β. In addition, it is also possible that the influence is limited in individuals with advanced hippocampal atrophy,[19] since the inverse relationships between ACC, precuneus and lateral temporal AV-45 SUVr with hippocampal volume were only found in our AD patients with a relatively preserved hippocampal volume. Taken together with previous findings, we suggest that the relationship between amyloid burden and lower memory performance[8,32] is more robust in healthy elderly subjects.[8,32] In contrast, when AD patients are in the dementia phase, only regional precuneus SUVr is associated with verbal fluency scores.[8]

Quantification of AV-45 Densities by MRI-Based GM Segmentation

According to the literature, most amyloid-imaging data provide insignificant linkage to cognitive performance in AD. A reason for this may be related to the quantification methods. As AV-45 shows nonspecific binding in white matter,[2,38] quantification of the amyloid-β burden focusing on the corresponding GM would theoretically be more straightforward. SUVr quantification in patients with GM atrophy based on an a priori anatomical template may overestimate the AV-45 retention density by sampling white matter signals. With regards to changes in GM volume, our GM segmentation-based SUVr quantification method was labor intensive and required manual rechecking to ensure correct coregistration in each subject. However, with individual MRI-based coregistration in SUVr quantification, the direct association of AV-45 SUVr with orientation score in this study reinforces the significance of this method.

STUDY LIMITATIONS AND CONCLUSION

The study limitations include a small sample size which may have led to the risk of type I and type II errors. As the analyses with specific cognitive assessments were exploratory, the reported P values in our results were unadjusted for multiple comparisons. The independent relationship between PCC SUVr and orientation performance was reported after careful statistical examination by correlational analysis, stepwise regression analysis, and rechecking the composite orientation score. In addition, there may have been selection bias in our population as they all only had mild stage AD. However, this was to avoid the oversaturation of AV-45 to directly explore the effect of amyloid burden on cognitive performance. In conclusion, our study indicates that amyloid burden within the ACC and PCC regions may contribute to local or distant interconnected DMN cortical hub GM atrophy. Although the orientation scores were related to PCC amyloid load, changes in hippocampal volume could explain the salient memory score.

Acknowledgments

The authors express their gratitude to the patients who participated in this project and Miss Chen Ching for performing the cognitive test scores.
  38 in total

Review 1.  Voxel-based morphometry--the methods.

Authors:  J Ashburner; K J Friston
Journal:  Neuroimage       Date:  2000-06       Impact factor: 6.556

2.  The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Authors:  Guy M McKhann; David S Knopman; Howard Chertkow; Bradley T Hyman; Clifford R Jack; Claudia H Kawas; William E Klunk; Walter J Koroshetz; Jennifer J Manly; Richard Mayeux; Richard C Mohs; John C Morris; Martin N Rossor; Philip Scheltens; Maria C Carrillo; Bill Thies; Sandra Weintraub; Creighton H Phelps
Journal:  Alzheimers Dement       Date:  2011-04-21       Impact factor: 21.566

3.  Hippocampal volume and retention in Alzheimer's disease.

Authors:  Joel H Kramer; Norbert Schuff; Bruce R Reed; Dan Mungas; An-Tao Du; Howard J Rosen; William J Jagust; Bruce L Miller; Michael W Weiner; Helena C Chui
Journal:  J Int Neuropsychol Soc       Date:  2004-07       Impact factor: 2.892

Review 4.  Functional heterogeneity in cingulate cortex: the anterior executive and posterior evaluative regions.

Authors:  B A Vogt; D M Finch; C R Olson
Journal:  Cereb Cortex       Date:  1992 Nov-Dec       Impact factor: 5.357

5.  Low plasma ApoE levels are associated with smaller hippocampal size in the Alzheimer's disease neuroimaging initiative cohort.

Authors:  Edmond Teng; Nicole Chow; Kristy S Hwang; Paul M Thompson; Karen H Gylys; Gregory M Cole; Clifford R Jack; Leslie M Shaw; John Q Trojanowski; Holly D Soares; Michael W Weiner; Liana G Apostolova
Journal:  Dement Geriatr Cogn Disord       Date:  2014-12-24       Impact factor: 2.959

6.  Amyloid deposition detected with florbetapir F 18 ((18)F-AV-45) is related to lower episodic memory performance in clinically normal older individuals.

Authors:  Reisa A Sperling; Keith A Johnson; P Murali Doraiswamy; Eric M Reiman; Adam S Fleisher; Marwan N Sabbagh; Carl H Sadowsky; Alan Carpenter; Mat D Davis; Ming Lu; Matthew Flitter; Abhinay D Joshi; Christopher M Clark; Michael Grundman; Mark A Mintun; Daniel M Skovronsky; Michael J Pontecorvo
Journal:  Neurobiol Aging       Date:  2012-08-09       Impact factor: 4.673

7.  Relationship between atrophy and beta-amyloid deposition in Alzheimer disease.

Authors:  Gaël Chételat; Victor L Villemagne; Pierrick Bourgeat; Kerryn E Pike; Gareth Jones; David Ames; Kathryn A Ellis; Cassandra Szoeke; Ralph N Martins; Graeme J O'Keefe; Olivier Salvado; Colin L Masters; Christopher C Rowe
Journal:  Ann Neurol       Date:  2010-03       Impact factor: 10.422

8.  Use of florbetapir-PET for imaging beta-amyloid pathology.

Authors:  Christopher M Clark; Julie A Schneider; Barry J Bedell; Thomas G Beach; Warren B Bilker; Mark A Mintun; Michael J Pontecorvo; Franz Hefti; Alan P Carpenter; Matthew L Flitter; Michael J Krautkramer; Hank F Kung; R Edward Coleman; P Murali Doraiswamy; Adam S Fleisher; Marwan N Sabbagh; Carl H Sadowsky; Eric P Reiman; P Eric M Reiman; Simone P Zehntner; Daniel M Skovronsky
Journal:  JAMA       Date:  2011-01-19       Impact factor: 56.272

9.  Amyloid plaques disrupt resting state default mode network connectivity in cognitively normal elderly.

Authors:  Yvette I Sheline; Marcus E Raichle; Abraham Z Snyder; John C Morris; Denise Head; Suzhi Wang; Mark A Mintun
Journal:  Biol Psychiatry       Date:  2009-10-14       Impact factor: 13.382

10.  Beta-amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia.

Authors:  P Bourgeat; G Chételat; V L Villemagne; J Fripp; P Raniga; K Pike; O Acosta; C Szoeke; S Ourselin; D Ames; K A Ellis; R N Martins; C L Masters; C C Rowe; O Salvado
Journal:  Neurology       Date:  2010-01-12       Impact factor: 9.910

View more
  17 in total

1.  Interhemispheric functional connectivity for Alzheimer's disease and amnestic mild cognitive impairment based on the triple network model.

Authors:  Zheng-Luan Liao; Yun-Fei Tan; Ya-Ju Qiu; Jun-Peng Zhu; Yan Chen; Si-Si Lin; Ming-Hao Wu; Yan-Ping Mao; Jiao-Jiao Hu; Zhong-Xiang Ding; En-Yan Yu
Journal:  J Zhejiang Univ Sci B       Date:  2018 Dec.       Impact factor: 3.066

2.  The cingulate cortex of older adults with excellent memory capacity.

Authors:  Feng Lin; Ping Ren; Mark Mapstone; Steven P Meyers; Anton Porsteinsson; Timothy M Baran
Journal:  Cortex       Date:  2016-11-19       Impact factor: 4.027

3.  Impacts of CD33 Genetic Variations on the Atrophy Rates of Hippocampus and Parahippocampal Gyrus in Normal Aging and Mild Cognitive Impairment.

Authors:  Wen-Ying Wang; Ying Liu; Hui-Fu Wang; Lin Tan; Fu-Rong Sun; Meng-Shan Tan; Chen-Chen Tan; Teng Jiang; Lan Tan; Jin-Tai Yu
Journal:  Mol Neurobiol       Date:  2016-01-23       Impact factor: 5.590

4.  Altered intrinsic regional spontaneous brain activity in patients with optic neuritis: a resting-state functional magnetic resonance imaging study.

Authors:  Yi Shao; Feng-Qin Cai; Yu-Lin Zhong; Xin Huang; Ying Zhang; Pei-Hong Hu; Chong-Gang Pei; Fu-Qing Zhou; Xian-Jun Zeng
Journal:  Neuropsychiatr Dis Treat       Date:  2015-12-11       Impact factor: 2.570

5.  Weight Rich-Club Analysis in the White Matter Network of Late-Life Depression with Memory Deficits.

Authors:  Naikeng Mai; Xiaomei Zhong; Ben Chen; Qi Peng; Zhangying Wu; Weiru Zhang; Cong Ouyang; Yuping Ning
Journal:  Front Aging Neurosci       Date:  2017-08-23       Impact factor: 5.750

6.  The effect of hippocampal function, volume and connectivity on posterior cingulate cortex functioning during episodic memory fMRI in mild cognitive impairment.

Authors:  Janne M Papma; Marion Smits; Marius de Groot; Francesco U Mattace Raso; Aad van der Lugt; Henri A Vrooman; Wiro J Niessen; Peter J Koudstaal; John C van Swieten; Frederik M van der Veen; Niels D Prins
Journal:  Eur Radiol       Date:  2017-03-13       Impact factor: 5.315

7.  Decreased N-Acetyl Aspartate/Myo-Inositol Ratio in the Posterior Cingulate Cortex Shown by Magnetic Resonance Spectroscopy May Be One of the Risk Markers of Preclinical Alzheimer's Disease: A 7-Year Follow-Up Study.

Authors:  Masaaki Waragai; Masaru Moriya; Takeshi Nojo
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

8.  Insula Volume and Salience Network Are Associated with Memory Decline in Parkinson Disease: Complementary Analyses of Voxel-Based Morphometry versus Volume of Interest.

Authors:  Yan-Ting Lu; Wen-Neng Chang; Chiung-Chih Chang; Cheng-Hsien Lu; Nai-Ching Chen; Chi-Wei Huang; Wei-Che Lin; Ya-Ting Chang
Journal:  Parkinsons Dis       Date:  2016-02-21

9.  Hippocampal Amyloid Burden with Downstream Fusiform Gyrus Atrophy Correlate with Face Matching Task Scores in Early Stage Alzheimer's Disease.

Authors:  Ya-Ting Chang; Chi-Wei Huang; Nai-Ching Chen; Kun-Ju Lin; Shu-Hua Huang; Wen-Neng Chang; Shih-Wei Hsu; Che-Wei Hsu; Hsiu-Hui Chen; Chiung-Chih Chang
Journal:  Front Aging Neurosci       Date:  2016-06-17       Impact factor: 5.750

10.  Dose-dependent genotype effects of BDNF Val66Met polymorphism on default mode network in early stage Alzheimer's disease.

Authors:  Pin-Hsuan Lin; Shih-Jen Tsai; Chi-Wei Huang; Liu Mu-En; Shih-Wei Hsu; Chen-Chang Lee; Nai-Ching Chen; Ya-Ting Chang; Min-Yu Lan; Chiung-Chih Chang
Journal:  Oncotarget       Date:  2016-08-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.